IPO Price History
Closed
Q-Line Biotech Ltd. logo

Q-Line Biotech Ltd. IPO

SME IPOListedQLINENSE SME
Current Market Price (CMP)
₹529.55(+54.39%)
Current Price (CMP)
₹529.55(+54.39%)

Live Market Quote

Listing Price & Gain
₹474.60(+38.37%)

Day 1 Exchange Open

IPO Issue Price
₹343

Band: ₹326 - ₹343

Total Subscription
95.31x

Overall Bid Demand

Total Issue Size
₹203.74 Cr

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
21 May 2026
IPO Bidding Closes
25 May 2026
Allotment & Refunds
Completed
Exchange Listing Day
29 May 2026

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 95.31x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)—
Non-Institutional Investors (NII / HNI)—
Retail Individual Investors (RII)—
Total Subscription95.31x
Updated as on null

Listing Day & Return Performance

Listing Day Gain+38.37%
₹343 (Issue) → ₹474.60 (List)
Per share profit: +₹131.60
Holding Return (Till Date)+54.39%
₹343 (Issue) → ₹529.55 (CMP)
Net gain per share: +₹186.55
Post-Listing Performance (Listing Day → Today):+11.58%

About Q-Line Biotech Ltd. IPO

Q-Line Biotech Ltd. is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 21 May 2026 and concluded on 25 May 2026, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹326 - ₹343. The aggregate issue size was approximately ₹203.74 crore.

During the bidding window, Q-Line Biotech Ltd. witnessed heavy demand with an overall subscription of 95.31 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Q-Line Biotech Ltd. officially debuted on the stock exchanges on 29 May 2026 at an opening listing price of ₹474.60, delivering a listing day return of +38.37% (premium) over the final issue price. As per the latest market data, the stock trades at ₹529.55, representing an overall gain of +54.39% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Q-Line Biotech Ltd. IPO?
The issue price of Q-Line Biotech Ltd. IPO was fixed at ₹343 per equity share. The indicative bidding price band was ₹326 - ₹343.
What was the total issue size of Q-Line Biotech Ltd. IPO?
The total issue size of Q-Line Biotech Ltd. IPO was approximately ₹203.74 crore.
What were the open, close, and listing dates for Q-Line Biotech Ltd. IPO?
Q-Line Biotech Ltd. IPO opened on 21 May 2026, closed on 25 May 2026, listed on 29 May 2026.
How much was Q-Line Biotech Ltd. IPO subscribed?
The IPO received an overall subscription of 95.31 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Q-Line Biotech Ltd. IPO?
Q-Line Biotech Ltd. IPO listed on the stock exchange at ₹474.60, delivering a listing gain of 38.37% compared to the IPO issue price of ₹343.
Is Q-Line Biotech Ltd. IPO a Mainboard or SME IPO?
Q-Line Biotech Ltd. IPO is a SME IPO listed on the SME platform of NSE SME.
What is the current return of Q-Line Biotech Ltd. IPO since its IPO?
At the latest market quote of ₹529.55, Q-Line Biotech Ltd. IPO has generated an all-time return of +54.39% since its initial public offering.

Related SME IPOs (2026)

SAIURJA
Sai Urja Indo Ventures Ltd.
₹113+18.41%
SKOFFSET
S.K.Offset Ltd.
₹125+0.80%
HNIL
Himalaya Nutravedics India Ltd.
₹106+11.32%
ANAND
Anand Seamless Ltd.
₹72+0.14%